CLINICAL_TRIALS
trial_result
· 2021-07-26
Clinical Trial Update: PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]
Summary
Phase 3 trial update for PRC-063 in adults with ADHD; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Purdue Pharma, Canada | Conditions: ADHD | Phase 3 | Status: COMPLETED | Results posted: 2021-07-26